BRIEF published on 11/12/2024 at 11:38, 9 days 2 hours ago EDX Medical to Present at Hardman & Co Investor Forum Webinar Growth Strategies Medical Diagnostics Investor Forum EDX Medical
PRESS RELEASE published on 11/12/2024 at 11:33, 9 days 2 hours ago Hardman & Co Video Event: EDX Medical (EDX) Investor Forum Hardman & Co Research presents an upcoming Investor Forum featuring EDX Medical (EDX) at 3:00pm on Thursday, 14 November 2024. Register to join an interactive session discussing medical diagnostics and growth strategies Hardman & Co Research Growth Strategies Medical Diagnostics Investor Forum EDX Medical
BRIEF published on 11/11/2024 at 15:05, 9 days 23 hours ago Shield Therapeutics to Present at Hardman & Co Investor Forum Sales Growth Online Event Shield Therapeutics Accrufer® Investor Forum
PRESS RELEASE published on 11/11/2024 at 15:00, 9 days 23 hours ago Hardman & Co Video Event: Shield Therapeutics (STX) Investor Forum Hardman & Co to host Shield Therapeutics (STX) Investor Forum on 14 Nov 2024. Register for insights into growth strategies and market leverage opportunities Hardman & Co Growth Strategies Shield Therapeutics Investor Forum Market Leverage
BRIEF published on 11/11/2024 at 14:15, 10 days ago Insight into Polar Capital Technology Trust with Hardman Talks Investment Strategies Market Insights Polar Capital Discounted Shares Technology Investing
PRESS RELEASE published on 11/11/2024 at 14:10, 10 days ago Hardman Talks Video | Polar Capital Technology Trust Interview Hardman & Co's CEO Keith Hiscock interviews Alastair Unwin, Deputy Manager of Polar Capital Technology Trust, discussing investment in the technology sector and the trust's market position Technology Sector Investment Companies Hardman & Co Polar Capital Technology Trust Market Cap
BRIEF published on 11/04/2024 at 14:20, 16 days 23 hours ago Windward to Showcase at Hardman & Co Investor Forum AI Growth EBITDA Profitability Market Strategies Windward Investor Forum
PRESS RELEASE published on 11/04/2024 at 14:15, 17 days ago Hardman & Co Video Event: Windward (WNWD) Investor Forum Hardman & Co to host a video event featuring Windward (WNWD) at the upcoming Investor Forum. Register to learn about the UK-listed AI company's growth and profitability prospects AI Company Hardman & Co Growth Prospects Windward Investor Forum
BRIEF published on 11/01/2024 at 13:05, 20 days 1 hour ago Understanding RECI's Discount and Market Prospects Real Estate Investment Strategy RECI Market Dynamics Discount Rate
PRESS RELEASE published on 11/01/2024 at 13:00, 20 days 1 hour ago Q&A on Real Estate Credit Investments: Understanding the discount, its rise, and future prospects Hardman & Co Research presents Q&A session on Real Estate Credit Investments, analyzing discount rate trends, strategies, and market outlook for RECI Plc Hardman & Co Research Market Outlook Real Estate Credit Investments Discount Rate RECI Plc
Published on 11/21/2024 at 14:00, 15 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 15 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 15 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 45 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 40 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 55 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
